HIGHFINE INSTITUTE OF BIOTECH

In November 2019, Highfine Biotech Polypeptide Synthesis Reagent R&D Headquarter Project was signed to be settled in Xushuguan Economic Development Zone. The headquarter covers an area of about 15 mu, with a total investment of 350 million yuan. Three buildings are being planned in this project, which are the office building of Highfine Biological Headquarter Building, the R&D center and the analysis center. Construction started in September 2021 and would be put into use by the end of 2022. Once the headquarter be completed, the research and development scale will rise fivefold, bringing capacity of accommodating 300 research and development personnel.

ANHUI PRODUCTION BASE

Anhui Highfine Biotech Co., Ltd. is located in the high-tech zone of Anqing. It was established in September 2018 with a registered capital of 100 million RMB. It is a subsidiary of Suzhou Highfine Biotech Co., Ltd. Covering an area of 59,000 m2, with a total investment of 300 million RMB, it was completed and put into operation in 2021.

 

There are comprehensive office buildings, research and development centers, 3 production workshops, raw materials and finished products warehouses and other facilities. DCS automatic control system improves production efficiency and safety. It is mainly used to carry out the projects of peptide reagents and protein cross-linking agents.

SERVICE ADVANTAGES

Milligrams to kilograms level  Custom synthesis service

Core Structure

Design and Development

 

Prodrug

Structural Optimization

 

Process

Development

and Optimization

 

Pilot experiment to large scale production of compounds